English
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Li Wei

Title: Chief Physician
Profile: Postdoctoral Fellow, Chief Physician, Professor, Doctoral Supervisor, Director of Oncology Center, Peking Tongren Hospital, Capital Medical University. He specializes in minimally invasive ablation, interventional and targeted immunotherapy for lung cancer, thyroid cancer, liver cancer, breast cancer and head and neck tumors, as well as the clinical application of innovative drugs and new diagnostic methods. He has been awarded “Beijing High-level Innovation and Entrepreneurial Talents (Leading Talents)”, “High-level Talents in Beijing Health System”, “Beijing Ten Million Talents Project” and “Capital Top 100 Excellent Physicians”. “Beijing Top 100 Outstanding Physicians” and other honors. He received his Bachelor's Degree in Clinical Medicine from Peking University School of Medicine, and his PhD in Medicine and Molecular Biology from the United States, and is qualified to practice medicine in the United States. He has received training in tumor interventional ablation techniques at Johns Hopkins Hospital in the United States. He is now an expert in the evaluation of new drugs/new medical devices by the State Food and Drug Administration, an expert in the evaluation of the National Health Insurance Administration, an expert in the evaluation of the National Natural Foundation of China, a director of the American College of Physicians, etc. He has held more than 30 positions as vice-chairman, standing committee member, and committee member of many branches of the Chinese Medical Association/Chinese Medical Doctors' Association. He has presided over a number of provincial and ministerial level/national level projects, including the sub-projects of the 12th Five-Year Plan, the National Natural Science Foundation of China (NSFC) and the Beijing Natural Science Foundation (BNSF), etc. He has undertaken/participated in about 20 research projects. He has undertaken/participated in about 20 research projects and has published more than 150 papers, including 90 SCI papers, more than 60 SCI papers as first/corresponding author, with a total impact factor of about 450 points. He was honored with the “Capital Top Ten Diseases Science and Technology Research Award for Innovative Scientific Achievements”.

Li Wei